UnicoCell

  • About
  • Cell Therapy
  • Products & services
  • News
  • Contact
  • 中文 / EN

Home > News > All News

News

    • Press Release
    • Events
All News
  • 2023-08-23 2023.8.15 UnicoCell received Acknowledgment letter of MF (Master File) from US FDA for UnicoCell Conditioned Medium (UCCM)

  • 2023-07-10 2023.7.10 Unicocell Biomed Enrolls First Participant in Phase III Clinical Trial for Knee Osteoarthritis

  • 2023-03-31 2023.3.31 Unicocell Biomed Joins Taiwan Extracellular Vesicle Industry-Academia Association as a Member of the STEERING COMMITTEE

  • 2023-03-03 2023.3.3 Unicocell Biomed Knee Osteoarthritis Treatment Receives FDA approval for Phase III Clinical Trial

  • 2023-02-14 2023.2.14 Unicocell Biomed New Drug Receives Certification from SNQ

  • 2023-02-08 2023.2.8 Approval Granted for Unicocell Biomed to Initiate Phase III Clinical Trial for Knee Osteoarthritis Treatment

  • 2022-12-26 2022.12.26 UnicoCell received Acknowledgment letter of DMF (Drug Master File) from US FDA for its allogeneic cell bank

  • 2022-12-03 2022.12.3 UnicoVial was granted the winner at the National Innovation Award Ceremony

  • 2022-11-18 2022.12.1- 12.4 Visit UnicoCell @2022 Healthcare+ Expo Taiwan

  • 2022-11-09 2022.11.9 UnicoVial has won the 19th National Innovation Award held by Institute for Biotechnology and Medicine Industry

  • «
  • 1
  • 2
  • 3
  • »
1 page / total 3
向榮生醫科技

11494 台北市內湖區民權東路六段13之20號5樓

Tel:886-2-2792-2699 FAX:886-2-2792-7890

E-Mail : info@unicocell.com

LinkedIn Facebook Line
Copyright © 2018-2023 向榮生醫科技股份有限公司